Antipodes Partners’s Confluent CFLT Stock Holding History

Antipodes Partners’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,659	Closed	-$290K	–	133
2025 Q3	$290K	Buy	+14,659	New	+$307K	0.01%	75

Other funds holding CFLT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Antipodes Partners's CFLT Position: Q4 2025 in Review

Antipodes Partners sold out of Confluent (CFLT) in Q4 2025, closing a stake of 14,659 shares — an estimated $290K sold.

Antipodes Partners first reported a position in CFLT in Q3 2025 and held it in 1 quarter. The position peaked at $290K in Q3 2025. 426 funds tracked by Wall St. Rank hold CFLT as of Q4 2025.

Antipodes Partners reported no remaining Confluent position as of Q4 2025 after selling out during the quarter.
Antipodes Partners sold 14,659 Confluent shares in Q4 2025, an estimated $290K.
Antipodes Partners first reported a position in Confluent in Q3 2025 and held it in 1 quarter.
Antipodes Partners's Confluent position peaked at $290K in Q3 2025.
426 funds tracked by Wall St. Rank held Confluent as of Q4 2025.

Based on Antipodes Partners's 13F filing for Q4 2025, filed 5 Feb 2026.